NDC 46066-187 - Aspen Sodium Salicylate 60% with Caffeine 5.7%
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 46066-187
- Package NDCs from labels
- 46066-187-93
- Manufacturer
- Aspen Veterinary Resources, Ltd.
- Effective date
- 2023-12-29
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Aspen Sodium Salicylate 60% with Caffeine 5.7% | Aspen Veterinary Resources, Ltd. | 2023-12-29 | OTC ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 46066-187-93 | Aspen Sodium Salicylate 60% with Caffeine 5.7% | 3.79 L in 1 JUG | LIQUID | 3.79 | 1 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Excedrin Migraine | ACETAMINOPHEN, ASPIRIN, AND CAFFEINE | A-S Medication Solutions | d012ed1d-b256-48ec-b988-f226c2c5ae9e | 2024-05-29 | Warnings | 3G6A5W338E |
| Allergies | APIS MELLIFICA, ECHINACEA, HYDRASTIS CANADENSIS, TARAXACUM OFFICINALE, ACONITUM NAPELLUS, AETHUSA CYNAPIUM, AGARICUS MUSCARIUS, ALETRIS FARINOSA, ALFALFA, ALLIUM CEPA, ALLIUM SATIVUM, AMBROSIA ARTEMISIAEFOLIA, ARSENICUM ALBUM, ARTEMISIA VULGARIS, ARUNDO MAURITANICA, AVENA SATIVA, BELLADONNA, BELLIS PERRENIS, BOVISTA, BROMIUM, BRYONIA, CAFFEINUM, CALCAREA CARBONICA, CALLUNA VULGARIS, FLOS, CAPSICUM ANNUUM, CAT HAIR, CHAMOMILLA, CHELIDONIUM MAJUS, CHENOPODIUM ANTHELMINTICUM, CINNAMOMUM | Newton Laboratories, Inc. | 9d5dea47-5103-21a3-e053-2995a90aee78 | 2024-05-20 | Warnings | 3G6A5W338E |
| Headache Relief | ACETAMINOPHEN, ASPIRIN, CAFFEINE | WALGREENS | 07d34e7a-c0c6-f3c4-e063-6294a90aa5c3 | 2024-05-18 | Warnings | 3G6A5W338E |
| AMAZON BASIC CARE MIGRAINE RELIEF | ACETAMINOPHEN, ASPIRIN AND CAFFEINE | Amazon.com Services LLC | 113e8e06-16f2-9341-e063-6294a90af349 | 2024-05-15 | Warnings | 3G6A5W338E |
| Ear Ring | ALLIUM CEPA, ARGENTUM NITRICUM, CHENOPODIUM ANTHELMINTICUM, DULCAMARA, GINKGO BILOBA, CHININUM SULPHURICUM, CARTILAGO SUIS, MUCOSA NASALIS SUIS, ASARUM CANADENSE, ONOSMODIUM VIRGINIANUM, NATRUM SALICYLICUM, CARBO VEGETABILIS, CARBONEUM SULPHURATUM, CYCLAMEN EUROPAEUM, GOSSYPIUM HERBACEUM, GRAPHITES, KREOSOTUM, PHOSPHORUS, PLUMBUM METALLICUM, THERIDION, ZINCUM METALLICUM | Deseret Biologicals, Inc. | 43585c0d-50da-411d-9f26-c8c0325dd9d5 | 2024-05-08 | Warnings | WIQ1H85SYP |
| BUTALBITAL, ACETAMINOPHEN AND CAFFEINE | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE | QUAGEN PHARMACEUTICALS LLC | 8438f08f-a32a-4180-9030-e0fd5da4be30 | 2024-05-07 | Boxed warning, Warnings, Adverse reactions | 3G6A5W338E |
| BUTALBITAL, ACETAMINOPHEN AND CAFFEINE | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE | QUAGEN PHARMACEUTICALS LLC | 24813ec6-0111-4782-9182-a2b93501a2bc | 2024-05-06 | Boxed warning, Warnings, Adverse reactions | 3G6A5W338E |
| Extra Strength Pain Reliever | ACETAMINOPHEN, ASPIRIN, AND CAFFEINE | JHK Inc dba American Safety & First Aid | 87c5ad71-0448-4e0f-acee-bf9a1d38675e | 2024-04-25 | Warnings | 3G6A5W338E |
| Excedrin Extra Strength Pain Reliever | ACETAMINOPHEN, ASPIRIN (NSAID), AND CAFFEINE | Haleon US Holdings LLC | a71074a6-cc19-4bb3-8c84-4e82a8906801 | 2024-04-22 | Warnings | 3G6A5W338E |
| Handy Solutions Headache Pain Relief | ACETAMINOPHEN, ASPIRIN, CAFFEINE | Navajo Manufacturing Company Inc. | e5481abe-6971-2bc5-e053-2995a90ae895 | 2024-04-15 | Warnings | 3G6A5W338E |
| Headache Relief Extra Strength | ACETAMINOPHEN, ASPIRIN, CAFFEINE | H E B | 4d572228-3141-4539-9c3d-2fd06e94eee3 | 2024-04-09 | Warnings | 3G6A5W338E |
| Excedrin Extra Strength Pain Reliever | ACETAMINOPHEN, ASPIRIN (NSAID), AND CAFFEINE | Haleon US Holdings LLC | 1b5ff867-5442-4cf8-bd1e-530093cc88f8 | 2024-04-05 | Warnings | 3G6A5W338E |
| Excedrin Extra Strength Pain Reliever | ACETAMINOPHEN, ASPIRIN (NSAID), AND CAFFEINE | Haleon US Holdings LLC | 0faa3592-4d56-4645-9a0e-066e0bdfebb6 | 2024-04-05 | Warnings | 3G6A5W338E |
| Butalbital, Acetaminophen, Caffeine and Codeine Phosphate | BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE | Bryant Ranch Prepack | 215e2a6f-ec32-4836-8fad-22c8b40ba1f1 | 2024-04-04 | Boxed warning, Warnings, Adverse reactions | 3G6A5W338E |
| Butalbital, Acetaminophen and Caffeine | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE | Bryant Ranch Prepack | e9dffed5-d615-4e63-9860-c0f6f23848a1 | 2024-04-03 | Boxed warning, Warnings, Adverse reactions | 3G6A5W338E |
| Signature Care Migraine Relief | ACETAMINOPHEN, ASPIRIN, CAFFEINE | Safeway | 66695667-97a3-4329-8ce0-0fffa8628951 | 2024-03-27 | Warnings | 3G6A5W338E |
| Headache Relief Extra Strength | ACETAMINOPHEN, ASPIRIN, CAFFEINE | Family Dollar (FAMILY WELLNESS) | 650cb15e-c448-4df3-b0f8-4398be05d841 | 2024-03-27 | Warnings | 3G6A5W338E |
| Headache Relief Extra Strength | ACETAMINOPHEN, ASPIRIN, CAFFEINE | Dolgencorp, Inc. (DOLLAR GENERAL & REXALL) | 5ffcc78d-9163-4cb4-8811-ae9f0142806a | 2024-03-18 | Warnings | 3G6A5W338E |
| Dizzy | CEREBELLUM (SUIS), BRYONIA (ALBA), PETROLEUM, TABACUM, AMBRA GRISEA, CYCLAMEN EUROPAEUM, NATRUM SALICYLICUM, ARGENTUM NITRICUM, ASARUM CANADENSE, CALCAREA SULPHURICA, CARBONEUM SULPHURATUM, CHININUM SULPHURICUM, COCCULUS INDICUS, CONIUM MACULATUM, DIGITALIS PURPUREA, GELSEMIUM SEMPERVIRENS, PHOSPHORUS, PIPER METHYSTICUM, SILICEA, THERIDION | Deseret Biologicals, Inc. | fdf934f8-7b12-4076-b8fb-00c095940697 | 2024-03-15 | Warnings | WIQ1H85SYP |
| Excedrin Extra Strength Pain Reliever | ACETAMINOPHEN, ASPIRIN (NSAID), AND CAFFEINE | Haleon US Holdings LLC | 691b754c-bafc-47e2-a322-cf56245c01f6 | 2024-03-14 | Warnings | 3G6A5W338E |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.